Trials / Recruiting
RecruitingNCT05464992
Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- Centre Paul Strauss · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Standard Magnetic Resonance Imaging (MRI) is based on the excitation of hydrogen nuclei that are presents in water molecules, which abundance in human body allows for obtention of superior contrast. However, assessing the presence of other molecules than water in tissues is also of great clinical interest to probe metabolites related to physiological body function and pathological conditions. Chemical exchange saturation transfer (CEST) allow to overcome some limitations of proton magnetic resonance spectroscopy (1H-MRS) by exploiting chemical properties of the targeted molecule through a continuous process of re-saturation and exchange, and thus detecting it with increased sensitivity, from two orders of magnitude. Moreover, CEST technique is based on imaging sequences and can therefore benefit from well-known fast acquisition strategies, as well as improved spatial resolution.
Detailed description
For this study the investigators propose to include an additional CEST sequence in standard PET/MRI exam in order to obtain a cartography with biochemical informations from tissues in patients with glioma or brain metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Additional CEST sequences during PET/MRI exam | CE-Marked Advanced Technology Software Modules (ATSM) for Magnetic Resonance Imaging from General Electric Healthcare |
Timeline
- Start date
- 2022-12-28
- Primary completion
- 2036-12-28
- Completion
- 2036-12-28
- First posted
- 2022-07-19
- Last updated
- 2026-02-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05464992. Inclusion in this directory is not an endorsement.